5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 37.76▲ | 37.85▼ | 37.84▼ | 35.93▲ | 33.15▲ |
MA10 | 37.80▼ | 37.87▼ | 37.59▲ | 33.15▲ | 31.76▲ |
MA20 | 37.90▼ | 37.52▲ | 36.84▲ | 32.35▲ | 30.04▲ |
MA50 | 37.90▼ | 36.22▲ | 33.99▲ | 31.21▲ | 31.55▲ |
MA100 | 37.58▲ | 33.76▲ | 32.50▲ | 29.74▲ | 31.69▲ |
MA200 | 36.84▲ | 32.51▲ | 32.19▲ | 30.31▲ | 26.15▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.023▼ | -0.087▼ | -0.065▼ | 0.730▲ | 0.873▲ |
RSI | 41.557▼ | 66.281▲ | 76.167▲ | 73.922▲ | 68.547▲ |
STOCH | 16.961▼ | 52.546 | 84.589▲ | 82.211▲ | 72.821 |
WILL %R | -84.615▼ | -36.364 | -16.364▲ | -4.027▲ | -3.677▲ |
CCI | -64.549 | 5.914 | 66.872 | 162.125▲ | 255.272▲ |
▲ RSI&STOCH | $COLL Overbought RSI + Stochastic | Set Alert |
Tuesday, August 12, 2025 03:24 AM
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 29.4% year on year to $188 million. The company’s full ...
|
Saturday, August 09, 2025 05:49 PM
Detailed price information for Collegium Pharma (COLL-Q) from The Globe and Mail including charting and trades.
|
Saturday, August 09, 2025 06:56 AM
NasdaqGS:COLL 1 Year Share Price vs Fair Value Explore Collegium Pharmaceutical's Fair Values from the Community ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/08/25 | 37.92 | 38.13 | 37.67 | 37.77 | 162,994 |
12/08/25 | 36.47 | 37.89 | 36.0373 | 37.87 | 537,270 |
11/08/25 | 35.14 | 36.63 | 34.93 | 36.14 | 641,491 |
08/08/25 | 33.30 | 34.99 | 33.28 | 34.93 | 809,607 |
07/08/25 | 31.48 | 33.47 | 31.40 | 32.94 | 900,873 |
06/08/25 | 31.04 | 31.20 | 29.70 | 29.75 | 424,437 |
05/08/25 | 30.96 | 31.21 | 30.54 | 31.10 | 212,868 |
04/08/25 | 30.00 | 31.375 | 30.00 | 31.09 | 321,344 |
01/08/25 | 29.86 | 30.92 | 29.19 | 30.07 | 445,406 |
31/07/25 | 30.32 | 30.68 | 29.73 | 29.86 | 237,691 |
|
|
||||
|
|
||||
|
|